Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page
- Check5 days agoChange DetectedStudy status updated to Completed and the Study Completion (Actual) date shown as 2026-03-09. The previous Active, not recruiting label and its related values were removed.SummaryDifference0.4%

- Check12 days agoChange DetectedThe study documents reference has been updated to revision v3.6.3, replacing the previous v3.6.2. This indicates the trial materials have been refreshed to the latest revision.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2. This indicates a new version of the page content, typically reflecting backend updates or minor edits, without changing the study details displayed.SummaryDifference0.1%

- Check34 days agoChange DetectedAdds a recruitment notice No longer looking for participants and new help/navigation sections How to Read a Study Record, Common Questions, How to Join a Study. Updates the header Intervention / Treatment to Intervention/Treatment and appends a site revision note Revision: v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now shows revision v3.5.5, replacing v3.5.4, indicating a small backend update to the page's versioning.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision tag was updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page's documentation/versioning. It does not change trial information or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.